|
Volumn 23, Issue 3, 2009, Pages 429-431
|
Multidrug-experienced HIV-1-infected women demonstrated similar virological and immunological responses to tipranavir/ritonavir compared with men
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ASPARTATE AMINOTRANSFERASE;
ENFUVIRTIDE;
PROTEINASE INHIBITOR;
RITONAVIR;
RITONAVIR PLUS TIPRANAVIR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
VIRUS RNA;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
ARTICLE;
ASPARTATE AMINOTRANSFERASE BLOOD LEVEL;
BLEEDING;
CD4 LYMPHOCYTE COUNT;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG RESPONSE;
DRUG SAFETY;
FAT REDISTRIBUTION;
FEMALE;
HEPATITIS;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION;
HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT;
HYPERGLYCEMIA;
HYPERLIPIDEMIA;
IMMUNE RESPONSE;
ISCHEMIC HEART DISEASE;
KIDNEY FAILURE;
LOGISTIC REGRESSION ANALYSIS;
MAJOR CLINICAL STUDY;
MALE;
PANCREATITIS;
PRIORITY JOURNAL;
PROTEINASE INHIBITION;
QT PROLONGATION;
RANDOMIZED CONTROLLED TRIAL;
RASH;
SEX DIFFERENCE;
SIDE EFFECT;
SYSTEMIC INFECTION;
VIRUS LOAD;
ANTI-HIV AGENTS;
DRUG COMBINATIONS;
DRUG RESISTANCE, MULTIPLE, VIRAL;
FEMALE;
HIV INFECTIONS;
HIV-1;
HUMANS;
MALE;
PYRIDINES;
PYRONES;
RITONAVIR;
SEX FACTORS;
TREATMENT OUTCOME;
|
EID: 59949106038
PISSN: 02699370
EISSN: None
Source Type: Journal
DOI: 10.1097/QAD.0b013e3283229f81 Document Type: Article |
Times cited : (11)
|
References (7)
|